The Black Box Warning Is Gone. Should You Rethink Hormone Therapy?

13 hours ago

5 min read

By JoBeth Augustyniak, DO

Board-Certified Family Medicine (AOBFP)

Published October 27, 2026 · Medically reviewed by JoBeth Augustyniak, DO on October 27, 2026

About the author →

If you're in your 40s or 50s, waking up drenched at 2 a.m., and someone once told you hormone therapy "causes breast cancer," this post is for you. The rules around menopausal hormone therapy changed in a big way, and a lot of women never got the memo.

In my practice, the goal for most women asking about hormones is simple: sleep through the night again, think clearly, protect their bones and heart, and feel like themselves. Not chase a lab number. So let's talk about what actually changed, what the evidence says, and who this may (or may not) be right for.

What Changed

In November 2025, the FDA announced it was removing most of the black box warnings from menopausal hormone therapy products. Those warnings had been in place since 2003, after early results from the Women's Health Initiative (WHI) linked hormones to heart disease, stroke, breast cancer, and dementia.

The update also dropped the old advice to use "the lowest dose for the shortest time possible." That phrase shaped how a whole generation of doctors prescribed, or didn't.

One boxed warning remains: estrogen taken without a progestogen raises the risk of endometrial (uterine) cancer in women who still have a uterus. That one stays because it's real, and it's easy to manage with the right regimen.

Why the change? Twenty-plus years of follow-up showed the original WHI findings didn't apply evenly. The women in that study averaged about 63 years old, many a decade or more past menopause. When researchers looked at women who started hormones younger and closer to menopause, the picture looked very different.

What Hormone Therapy Actually Is

Menopausal hormone therapy (MHT, sometimes called HRT) replaces some of the estrogen your ovaries stop making. It comes in a few main forms:

Estrogen, given as a patch, gel, spray, pill, or vaginal cream, ring, or insert
A progestogen (often micronized progesterone), added for women with a uterus to protect the uterine lining
Low-dose vaginal estrogen, used on its own for dryness, painful sex, and recurrent urinary symptoms, with very little absorbed into the bloodstream

How it's delivered matters. Prescribing across the U.S. has been shifting toward patches, gels, and vaginal products and away from pills. Estrogen through the skin skips the first pass through the liver, which is thought to lower clotting risk compared with oral estrogen.

What the Evidence Says

Use	Evidence tier
Hot flashes and night sweats	Proven
Vaginal dryness, painful sex, urinary symptoms (genitourinary syndrome of menopause)	Proven
Preventing bone loss and fractures	Proven
Women with early or premature menopause (hormone replacement until the usual age of menopause)	Proven
Better weight loss alongside a GLP-1 medication	Promising
Preventing heart disease or dementia	Not a reason to start on its own

The upside. For hot flashes and night sweats, nothing works better than estrogen. The Menopause Society and the UK's NICE both support offering it to women with bothersome symptoms. New research presented at ENDO 2026 also found hormone therapy increased bone density at every site measured.

The long-term WHI follow-up is reassuring, too. Hormone therapy was not linked to higher death rates in any age group, and women on estrogen alone (after hysterectomy) actually had lower breast cancer rates over time. A 2026 analysis found no link between hormone therapy and mild cognitive impairment or dementia.

And here's the gap: even among women aged 50 to 59, the group most likely to benefit, only about 3.5% were using hormone therapy in 2023, according to a Mayo Clinic study. Researchers pointed to lingering fear and to doctors who were never well trained in menopause care.

The Limits: Timing Still Matters

A removed warning doesn't mean hormones are right for everyone. It means the decision belongs back in the exam room, between you and a doctor who knows your history.

Timing is the biggest factor. The benefits clearly outweigh the risks for most healthy women who start before age 60 or within 10 years of their last period. Starting later is a different conversation. A February 2026 study found that beginning hormone therapy after age 65 was tied to significantly higher risks of cancer and vascular events.

Combined therapy still carries some breast cancer signal. Risk looks more tied to estrogen plus a progestogen than to estrogen alone. The type of progestogen and how long you use it are part of the discussion.

It doesn't replace the basics. Hormones won't build muscle for you, fix sleep apnea, or undo insulin resistance on their own. They work best as one part of a bigger plan.

The GLP-1 Connection

This is where hormone health and metabolic health meet. A 2026 study of postmenopausal women taking tirzepatide (Zepbound or Mounjaro) found that women also on hormone therapy lost significantly more weight than women on tirzepatide alone, about 35% more.

I find that genuinely exciting, but I want to be honest about it. This was a retrospective study, meaning researchers looked back at records rather than randomly assigning treatment. Women who use hormone therapy may differ in other ways, too. I'd call it Promising, not proven.

What it does reinforce is something I see every week: estrogen loss changes where your body stores fat, how you handle blood sugar, and how well you sleep. Treating the metabolic side without asking about the hormonal side often leaves results on the table. If you're on a GLP-1, protecting your muscle with enough protein still matters just as much.

Who May Benefit, and Who Should Be Careful

Hormone therapy may be worth discussing if you:

Are under 60 or within about 10 years of your last period
Have hot flashes, night sweats, or sleep disruption that affect your days
Have vaginal dryness, painful sex, or recurring urinary symptoms
Have low bone density or a family history of osteoporosis
Went through menopause early (before 45)

It may not be right, or needs a more careful plan, if you have:

A personal history of breast or uterine cancer
A prior blood clot, stroke, or heart attack
Active liver disease
Unexplained vaginal bleeding that hasn't been evaluated
A start date more than 10 years past menopause, or age over 60

If you don't qualify, or don't want hormones, there are good non-hormonal options. Research at ENDO 2026 found fezolinetant, a non-hormonal medication for hot flashes, also improved depression and anxiety scores in menopausal women.

Your Next Step

Most midlife women get their care from a primary care doctor, not a menopause specialist. A recent JAMA commentary made the point that menopause care has to reach primary care for that reason. I agree. It's a big part of why I built Attune the way I did.

A good hormone conversation takes more than a 15-minute visit. We look at your symptoms, your personal and family history, your labs, your bone and heart risk, and your goals. Then we decide together, and we adjust as you go. As an Attune member, you can text me when something feels off instead of waiting six weeks for a follow-up.

If you're in Texas, Florida, Louisiana, or Oklahoma and wondering whether hormone therapy makes sense for you, book a free Discovery Call. No pressure, just a real conversation.